Loading…
Loading…
SLNO (Soleno Therapeutics, Inc.) is no longer actively trading.
This usually means the company was acquired and taken private, delisted from its exchange, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.
| APGE | Apogee Therapeutics, Inc. | $134.20 | $8.3B |
| PRAX | Praxis Precision Medicines, Inc. | $317.87 | $6.7B |
| CNTA | Centessa Pharmaceuticals plc | $40.50 | $6.3B |
| MIRM | Mirum Pharmaceuticals, Inc. | $117.05 | $5.9B |
| XENE | Xenon Pharmaceuticals Inc. | $66.74 | $5.3B |
| CELC | Celcuity Inc. | $91.69 | $4.5B |
| VKTX | Viking Therapeutics, Inc. | $37.95 | $4.4B |
| DYN | Dyne Therapeutics, Inc. | $23.83 | $3.9B |
| RARE | Ultragenyx Pharmaceutical Inc. | $28.62 | $2.8B |
| AAPG | Ascentage Pharma Group International | $19.10 | $1.8B |